Supercharging the Body's own defenses to fight Hard-to-Treat GIST
Disease control
Not yet recruiting
This trial tests whether a patient's own immune cells, called tumor-infiltrating lymphocytes (TILs), can be grown in a lab and then given back to fight advanced gastrointestinal stromal tumors (GIST). The study includes people whose GIST has spread, come back, or cannot be remove…
Phase: PHASE2 • Sponsor: Joal Beane • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC